Excelsoft Technologies IPO Day 3: Issue Booked 13.62x So Far
Global vertical SaaS company Excelsoft Technologies opened its Initial Public Offering (IPO) on November 19, 2025. The Company enters its final day of bidding today on November 21, 2025. The basis of allotment for Excelsoft Technologies IPO will be finalised on November 24, 2025, and the tentative listing date on BSE and NSE is November 26, 2025.
Excelsoft Technologies IPO Details
Excelsoft Technologies IPO is a book-building issue of ₹500 crores, consisting of a fresh issue of ₹180 crores and an offer for sale of ₹320 crores by promoter Pedanta Technologies Private Limited.
The price band is set between ₹114 and ₹120 per share. The lot size for an application is 125 and the minimum investment amount for retail investors is ₹15,000 (125 shares) based on upper price. Anand Rathi Advisors Ltd. is the book running lead manager and MUFG Intime India Pvt.Ltd. is the registrar of the issue.
Excelsoft Technologies IPO Day 3 Subscription Status
[21 November, 2025, 11:48 AM]
|
Investor Category |
Subscription (Times) |
|
Qualified Institutional Buyers (QIBs) |
0.22 |
|
Non-Institutional Investors |
41.69 |
|
Retail Individual Investors (RIIs) |
9.24 |
|
Total |
13.62 |
Explore other Upcoming IPOs on BSE and NSE.
Utilisation of Proceeds
The net proceeds from the fresh will be used towards the following purposes:
- Funding capital expenditure towards the purchase of land and construction of a new building located in the Mysore District.
- Upgrading external electrical systems at the existing facility.
- Upgrading the Company’s IT Infrastructure.
- General corporate purposes.
Check out newly Listed IPOs on BSE and NSE.
About Excelsoft Technologies
Excelsoft Technologies is a global vertical SaaS provider specialising in technology solutions for the learning, training, and assessment ecosystem. The company also offers a comprehensive range of learning solutions that support digital content distribution, subscription management, interactive learning experiences, and institutional training needs.
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here